跳至主要内容
临床试验/EUCTR2010-022506-41-IT
EUCTR2010-022506-41-IT进行中(未招募)不适用

A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC) - Induction and Maintenance Study of BMS-936557 Patients with Moderate to Severe Ulcerative Colitis

Bristol-Myers Squibb International Corporation0 个研究点目标入组 386 人开始时间: 2011年12月28日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
386

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Clinical diagnosis of moderate to severe UC confirmed by endoscopic and histologic evidence • Mayo score `?¥6 with an endoscopic subscore of `?¥2 • Inadequate response and/or intolerance to one or more conventional therapy (i.e. oral aminosalicylates, immunosuppressants, corticosteroids, and/or TNF antagonist)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Diagnosis of Crohn`??s Disease or Indeterminate Colitis • Diagnosis of UC that is limited to the rectum • Evidence of fulminant colitis, toxic megacolon, or bowel perforation • Current need for a colostomy or ileostomy • Previous total or subtotal colectomy

研究者

相似试验

A Phase IIb Randomized, Placebo-Controlled Study to... | 临床试验